We have general idea on the direction of Lympro and Elto. Any new update would have to include capital raise through Reg A, ESS and a new CEO. I don't see us have partners on MANF yet.
Interesting that someone is attempting to unload shares at current price (1.5 mil @ 0.0251).
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links